RxDoctor Payments Data

Natalie Nichols, PA

Physician Assistant · Ventura, CANPI 1821745373

Payments from drug & device makers

$1,549in general payments, 2019–2025

Across 52 payments — averaging $29.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Radius Health, Inc.$305
  • Silk Road Medical, Inc.$150
  • Novo Nordisk$142
  • Abbott$123
  • Amgen$120
  • Nevro Corp.$108
  • plus $601 from 13 others

What the payments were for

  • Food & beverage$1,549100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,549 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$57,704
Medicare patients
252
Services billed
695

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$47,272
EliquisApixaban24$25,021
JanumetSitagliptin Phos/Metformin Hcl13$22,819
TrulicityDulaglutide14$17,932
MyrbetriqMirabegron16$14,765
XareltoRivaroxaban11$10,811
Atorvastatin Calcium281$3,426
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$2,137
Estradiol24$1,919
SynthroidLevothyroxine Sodium31$1,902
Levothyroxine Sodium161$1,673
Amlodipine Besylate240$1,532
Albuterol Sulfate HfaAlbuterol Sulfate80$1,501
Lisinopril172$1,415
Memantine Hcl ErMemantine Hcl11$1,209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$142$47,27229 claims
PfizerEliquis$17$25,02124 claims
Lilly USA, LLCTrulicity$87$17,93214 claims
Almatica Pharma LLCSertraline Hcl$19$71163 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Ventura

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →